拜耳将美国草甘膦业务剥离至Ruveon
2026-07-02 08:37:24
据彭博社报道，拜耳公司(Bayer AG)将其美国草甘膦业务装入名为Ruveon的实体。此举被视为试图限制与其Roundup除草剂致癌指控相关的诉讼风险。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Next article：
股票市场 | 网易将纳入恒生指数系列成份股
